title: Comparison of bronchial hyperresponsiveness to methacholine and adenosine and airway inflammation markers in patients with suspected asthma.
abstract: BACKGROUND
  Bronchial hyperresponsiveness is usually measured by bronchial challenge test with direct (e.g., methacholine) and indirect (e.g., adenosine) agonists. There are few studies comparing both types of agents and they have had conflicting concordance.
  
  
  OBJECTIVE
  We sought to compare the results of both tests in a population with symptoms suggestive of asthma so as to determine their relationship with bronchial inflammatory markers.
  
  
  METHODS
  Seventy-nine patients whose age ranged from 14 to 81 years were recruited for this study. Challenge tests were performed using the tidal volume method. PC₂₀ methacholine and PC₁₅ and PC₂₀ adenosine were calculated. Induced sputum and fraction of exhaled nitric oxide measurements were also performed.
  
  
  RESULTS
  Atopy was found in 69% of the patients. Methacholine PC₂₀ and adenosine PC₁₅ were positive in 32 patients (40.5%), both having a sensitivity of 73%. Percentage of agreement was 45.45% and κ index was only 0.369. Adenosine PC₂₀ elicited lower sensitivity and agreement. No correlation between methacholine PC₂₀ and adenosine PC₁₅ was observed. Higher fraction of exhaled nitric oxide values and sputum eosinophil counts were seen in patients with positive adenosine challenge results. The use of adenosine PC₁₅ or PC₂₀ did not alter the association with inflammatory markers.
  
  
  CONCLUSIONS
  The concordance between both techniques was low. Methacholine is not a reliable predictor of hyperresponsiveness to adenosine, leading us to conclude that the two tests are complementary but not interchangeable in clinical practice. Additionally, responsiveness to the two bronchoconstrictor stimuli does not indicate presence of the same airway abnormality. Indirect stimuli provide a better reflection of bronchial inflammation.
authors.affiliation: Allergy Department, Fundación Jiménez Díaz and CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.
authors.forename: Luis
authors.initials: L
authors.lastname: Manso
authors.forename: Mauro F
authors.initials: MF
authors.lastname: Madero
authors.forename: Mónica
authors.initials: M
authors.lastname: Ruiz-García
authors.forename: Mar
authors.initials: M
authors.lastname: Fernández-Nieto
authors.forename: Joaquín
authors.initials: J
authors.lastname: Sastre
mesh_terms: D000241:Adenosine; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001249:Asthma / Q000175:diagnosis*; D015415:Biomarkers / Q000032:analysis*; D001944:Breath Tests; D001980:Bronchi / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000175:diagnosis* / Q000503:physiopathology; D016085:Bronchoconstrictor Agents; D004804:Eosinophils / Q000166:cytology; D045853:Exhalation; D005260:Female; D006801:Humans; D007249:Inflammation / Q000175:diagnosis; D007958:Leukocyte Count; D008297:Male; D016210:Methacholine Chloride; D008875:Middle Aged; D009569:Nitric Oxide; D012680:Sensitivity and Specificity; D013183:Sputum / Q000166:cytology; D055815:Young Adult
chemical_list: D015415:Biomarkers; D016085:Bronchoconstrictor Agents; D016210:Methacholine Chloride; D009569:Nitric Oxide; D000241:Adenosine